Cite
Promotes Hepatocellular Carcinoma via Axis Under Insufficient Radiofrequency Ablation Condition.
MLA
Li, Zilin, et al. “Promotes Hepatocellular Carcinoma via Axis Under Insufficient Radiofrequency Ablation Condition.” Cancer Biotherapy & Radiopharmaceuticals, vol. 36, no. 10, Dec. 2021, pp. 879–87. EBSCOhost, https://doi.org/10.1089/cbr.2019.3541.
APA
Li, Z., Jiang, M., Zhang, T., & Liu, S. (2021). Promotes Hepatocellular Carcinoma via Axis Under Insufficient Radiofrequency Ablation Condition. Cancer Biotherapy & Radiopharmaceuticals, 36(10), 879–887. https://doi.org/10.1089/cbr.2019.3541
Chicago
Li, Zilin, Manhong Jiang, Ting Zhang, and Suhua Liu. 2021. “Promotes Hepatocellular Carcinoma via Axis Under Insufficient Radiofrequency Ablation Condition.” Cancer Biotherapy & Radiopharmaceuticals 36 (10): 879–87. doi:10.1089/cbr.2019.3541.